Literature DB >> 11581389

Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event.

M J Edwards1, N J Dimmock.   

Abstract

In standard neutralization (STAN), virus and antibody are reacted together before inoculation of target cells, and inhibition of almost any of the processes concerned in the early interaction of virus and cell, including inhibition of virus attachment to cell receptors, can be the cause of neutralization by a particular monoclonal antibody (MAb). To simplify the interpretation of antibody action, we carried out a study of postattachment neutralization (PAN), where virus is allowed to attach to target cells before neutralizing antibody is introduced. We used influenza virus A/PR/8/34 (H1N1) and monoclonal immunoglobulin G (IgG) molecules and their Fabs specific to antigenic sites Sb (tip), Ca2 (loop), and Cb (hinge) of the hemagglutinin 1 (HA1) protein. All IgGs and Fabs gave PAN, although with reduced efficiency compared with STAN. Thus, bivalent binding of antibody was not essential for PAN. By definition, none of these MAbs gave PAN by inhibiting virus attachment, and they did not elute attached virus from the target cell or inhibit endocytosis of virus. However, virus-cell fusion, as demonstrated by R18 fluorescence dequenching or hemolysis of red blood cells, was inhibited in direct proportion to neutralization and in a dose-dependent manner and was thus likely to be responsible for the observed neutralization. However, to get PAN, it was necessary to inhibit the activation of the prefusion intermediate, the earliest known form on the fusion pathway that is created when virus is incubated at pH 5 and 4 degrees C. PAN antibodies may act by binding HA trimers in contact with the cell and/or trimers in the immediate vicinity of the virus-cell contact point and so inhibit the recruitment of additional receptor-HA complexes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11581389      PMCID: PMC114595          DOI: 10.1128/JVI.75.21.10208-10218.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture.

Authors:  F M Ruggeri; H B Greenberg
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

2.  Neutralization of influenza virus by low concentrations of hemagglutinin-specific polymeric immunoglobulin A inhibits viral fusion activity, but activation of the ribonucleoprotein is also inhibited.

Authors:  S J Armstrong; N J Dimmock
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

3.  IgG-neutralized influenza virus undergoes primary, but not secondary uncoating in vivo.

Authors:  R J Rigg; A S Carver; N J Dimmock
Journal:  J Gen Virol       Date:  1989-08       Impact factor: 3.891

4.  Human immunodeficiency virus type 1 entry into T cells: more-rapid escape from an anti-V3 loop than from an antireceptor antibody.

Authors:  S Lu; S D Putney; H L Robinson
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

5.  Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms.

Authors:  C Wohlfart
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

6.  Fate of influenza A virion proteins after entry into subcellular fractions of LLC cells and the effect of amantadine.

Authors:  D D Richman; K Y Hostetler; P J Yazaki; S Clark
Journal:  Virology       Date:  1986-06       Impact factor: 3.616

7.  Intermediates in influenza induced membrane fusion.

Authors:  T Stegmann; J M White; A Helenius
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

8.  Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.

Authors:  Q J Sattentau; J P Moore
Journal:  J Exp Med       Date:  1991-08-01       Impact factor: 14.307

9.  Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation.

Authors:  J E Heuser; R G Anderson
Journal:  J Cell Biol       Date:  1989-02       Impact factor: 10.539

10.  Mechanisms of transmissible gastroenteritis coronavirus neutralization.

Authors:  C Suñé; G Jiménez; I Correa; M J Bullido; F Gebauer; C Smerdou; L Enjuanes
Journal:  Virology       Date:  1990-08       Impact factor: 3.616

View more
  22 in total

1.  Enhanced HIV-1 neutralization by antibody heteroligation.

Authors:  Hugo Mouquet; Malte Warncke; Johannes F Scheid; Michael S Seaman; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-04       Impact factor: 11.205

2.  An antibody against a novel and conserved epitope in the hemagglutinin 1 subunit neutralizes numerous H5N1 influenza viruses.

Authors:  Hsueh-Ling Janice Oh; Sara Akerström; Shuo Shen; Sándor Bereczky; Helen Karlberg; Jonas Klingström; Sunil K Lal; Ali Mirazimi; Yee-Joo Tan
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

3.  Bovine lactoferrin-derived peptides as novel broad-spectrum inhibitors of influenza virus.

Authors:  Maria Grazia Ammendolia; Mariangela Agamennone; Agostina Pietrantoni; Fabio Lannutti; Rosa Anna Siciliano; Beatrice De Giulio; Carla Amici; Fabiana Superti
Journal:  Pathog Glob Health       Date:  2012-03       Impact factor: 2.894

4.  Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity.

Authors:  Jerome P Jayasekera; E Ashley Moseman; Michael C Carroll
Journal:  J Virol       Date:  2007-01-03       Impact factor: 5.103

5.  Sindbis virus conformational changes induced by a neutralizing anti-E1 monoclonal antibody.

Authors:  Raquel Hernandez; Angel Paredes; Dennis T Brown
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

6.  Unraveling of a neutralization mechanism by two human antibodies against conserved epitopes in the globular head of H5 hemagglutinin.

Authors:  Mengran Qian; Hongxing Hu; Teng Zuo; Guiqin Wang; Linqi Zhang; Paul Zhou
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

7.  Different mechanisms of antibody-mediated neutralization of parvoviruses revealed using the Fab fragments of monoclonal antibodies.

Authors:  Christian D S Nelson; Laura M Palermo; Susan L Hafenstein; Colin R Parrish
Journal:  Virology       Date:  2007-01-09       Impact factor: 3.616

Review 8.  The Density Code for the Development of a Vaccine?

Authors:  Wei Cheng
Journal:  J Pharm Sci       Date:  2016-09-17       Impact factor: 3.534

9.  Structural basis for enhanced HIV-1 neutralization by a dimeric immunoglobulin G form of the glycan-recognizing antibody 2G12.

Authors:  Yunji Wu; Anthony P West; Helen J Kim; Matthew E Thornton; Andrew B Ward; Pamela J Bjorkman
Journal:  Cell Rep       Date:  2013-12-05       Impact factor: 9.423

10.  Few and far between: how HIV may be evading antibody avidity.

Authors:  Joshua S Klein; Pamela J Bjorkman
Journal:  PLoS Pathog       Date:  2010-05-27       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.